___

• 1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.Nature Microbiology 2020;5(4):536–544.
• 2. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
• 3. Cui J, Li F, Daszak P. Origin and evolution of pathogenic coronaviruses. Nat Rev Genet 2018; 17: 181–192.
• 4. Su S, Wong G, Shi W, Liu J, Lai A C K, Zhou J et al. Epidemiology, genetic recombination, and Pathogenesis of coronaviruses.Trends Microbiol 2016; 24(6):490–502. doi: 10.1016/j.tim.2016.03.003.
• 5. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348(20): 1953–1966.
• 6. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W et al. Coronavirus as a possible cause of severe acute respiratory syndrome.Lancet 2003; 361(9366):1319–1325. doi: 10.1016/S0140-6736(03)13077-2.
• 7. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA.Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367(19): 1814–1820 doi: 10.1056/NEJMoa1211721. Epub 2012 Oct 17. Erratum in: N Engl J Med. 2013 Jul 25;369(4):394.
• 8. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13(9):752–761. doi: 10.1016/S1473-3099(13)70204-4.
• 9. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome - coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 2020 Apr;63(4):119-124.doi: 10.3345/cep.2020.00493.
• 10. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature 2020, 579, 270.
• 11. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382 (8): 727−733.
• 12. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P et al. Commentary Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe 2020 Mar 11;27(3):325-328. doi: 10.1016/j.chom.2020.02.001. Epub 2020 Feb 7.
• 13. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020 May 5;133(9):1015-1024. doi: 10.1097/CM9.0000000000000722.
• 14. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster. Lancet 2020;395(10223):514-523.doi:10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
• 15. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses 2019;11(1):59. doi: 10.3390/v11010059.
• 16. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17(3):181–192. doi: 10.1038/s41579-018-0118-9.
• 17. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology 2020; 92 (4): 418-423. doi: 10.1002/jmv.25681.
• 18. Hasoksuz M, Sreevatson S, Cho KO, Hoet AE, Saif LJ. Molecular analysis of the S1 subunit of the spike glycoprotein of respiratory and enteric bovine coronavirus isolates. Virus Research 2002; 84 (1-2): 101-109. doi: 10.1016/S0168- 1702(02)00004-7.
• 19. Hasoksuz M, Lathrop S, Al-dubaib MA, Lewis P, Saif LJ. Antigenic variation among bovine enteric coronaviruses (BECV) and bovine respiratory coronaviruses (BRCV) detected using monoclonal antibodies. Archives of Virology 1999; 144 (12): 2441-2447.
• 20. Bosch BJ, Van Der Zee R, De Haan CAM, Rottier PJM. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. Journal of Virology 2003; 77 (16): 8801-8811. doi: 10.1128/JVI.77.16.8801-8811.2003.
• 21. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J. Pathol 2004; 203 (2): 631− 637.
• 22. Neuman B, Kiss G, Kunding A, Bhella D, Baksh MF, Connelly S et al. A structural analysis of M protein in coronavirus assembly and morphology. J Struct Boil 2010; 174: 11–22.
• 23. DeDiego ML, Álvarez E, Almazán F, Rejas MT, Lamirande E, Roberts A et al. A severe acute respiratory syndrome coronavirus that lacks the E Gene is attenuated in vitro and in vivo. J Virol 2006; 81: 1701–1713.
• 24. Fehr AR, Perlman S. Coronaviruses: An overview of their replication and pathogenesis. In Therapeutic Antibodies; Springer: Berlin/Heidelberg, Germany, 2015; Volume 1282, pp. 1–23.
• 25. Cui L, Wang H, Ji Y, Yang J, Xu S, Huang X et al. The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells. J Virol 2015; 89: 9029–9043.
• 26. Liu YC, Kuo RL, Shih SR. COVID-19: the First Documented Coronavirus Pandemic in History. Biomed J 2020 May 5:S2319-4170(20)30044-5. doi: 10.1016/j.bj.2020.04.007.
• 27. World Health Organization.Laboratory testing for coronavirus disease (COVID-19) in suspected human cases.19 March 2020.
• 28. Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections-the state of the art. Emerg Microbes Infect 2020; 9(1):747-56.
• 29. Kaye M, Druce J, Tran T, Kostecki R, Chibo D, Morris J, et al. SARS associated coronavirus replication in cell lines. Emerg Infect Dis 2006;12(1):128-133.
• 30. www.cdc.gov May 5, 2020. SARS CoV-2 viral culture at CDC.
• 31. Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, George K, et al. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of diagnostic testing for SARS-CoV-2/COVID-19. American Society for Microbiology 2020;11(2):1-4.
• 32. Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS CoV-2. Gene Reports 2020 Apr 16;19:100682.  doi: 10.1016/j.genrep.2020.100682.
• 33. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: The disease and tools for detection. ACS Nano 2020; 14: 3822-35.
• 34. Sheridan C. Coronavirus and the race to distribute reliable diagnostics. Nat Biotechnol 2020; DOI:10.1038/d41587-020-00002-2.
• 35. Miller S, Chiu C, Rodino KG, Miller MB. Point-counterpoint should we be performing metagenomic next-generation sequencing for infectious disease diagnosis in the clinical laboratory? J Clin Microbiol 2020; DOI:10.1128/JCM.01739-19.
• 36. Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR. Pitfalls and potential. BioTechniques 1999; 26(1):124-125.
• 37. Corman V, Bleicker T, Brünink S, Zambon M. Diagnostics detection of Wuhan Coronavirus 2019 by real-time RT-PCR. WHO: Geneva 2020.
• 38. CDC-2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel, Division of Viral Disease, U.S. Centers for Disease Control and Prevention: Atlanta GA, 2020.
• 39. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: Interim guidance, World Health Organization 2 March 2020.
• 40. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic testing for severe acute respiratory syndrome-related Coronavirus-2. Ann Intern Med Doi.10.7326/M20-1301.
• 41. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA, 2020 Feb, 27. doi:10.1001/jama2020.2783.
• 42. Zou L, Ruan F, Huang M, Liang L, Huang H, Hang Z, et al. SARS CoV-2 viral load in upper respiratory specimens of infected patients. N Eng J Med 2020; 382: (12):1177-79
• 43. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 2020; 20(4):411-12. 44. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveill 2020; 25(3):2000045.
• 45. Chu DK, Pan Y, Cheng SM, Hui KP, Krishnan P, Liu Y, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 2020; 66:549-55.
• 46. XpertXpress SARS-CoV-2. https://www.cepheid.com/coronavirus.
• 47. Abbott launches molecular point-of-care test to detect novel coronavirus in as little as five minutes. https://abbott.mediaroom.com/2020-03-27.
• 48. Xiang J, Yan M, Hongze L, Ting L, Chenyao L, Shueng H, et al. Evaluation of enzyme-linked immunoassay and colloidal gold- immunochromatographic assay kit for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19). medRxiv, doi: 10.1101/2020.02.22.20026617.
• 49. Bruning AHL, Aatola H, Toivola H, Ikonen N, Savolainen-Kopra C, Blomquist S, et al. Rapid detection and monitoring of human coronavirus infections. New Microbes New Infect 2018; 24:52-55.
• 50. Sheridan C. Fast portable tests come online to curb coronavirus pandemic. Nat Biotechnol 2020; doi:10.1038/d41587-020-00010-2.
• 51. Chan CM, Tse H, Wong SS, Woo PCY, Lau SKP, Chen L, et al. Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol 2009; 45(1):54-60.
• 52. Shao X, Guo X, Esper F, Weibel C, Kahn JS. Seroepidemiology of group I human coronaviruses in children. J Clin Virol 2007; 40(3):207-13.
• 53. Infantino M, Damiani A, Gobbi FL, Grossi V, Lari B, Macchia D, et al. Serological assays for SARS-CoV2 ınfectious disease:Benefits, limitations and perspectives.IMAJ 2020; 22:203-10.
• 54. Che XY, Qiu LW, Liao ZY, Wang YD, Wen K, Pan YX, et al. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis 2005;191:2033-7.
• 55. Carattoli A, Di Bonito P, Grasso F, Giorgi C, Blasi F, Niedrig M, et al. Recombinant protein‐based ELISA and immuno‐cytochemical assay for the diagnosis of SARS. J Med Virol 2005; 76:137-42.
• 56. Walls AC, Park YJ, Tortorici MA, Wall A, MacGuire AT, Veesler D. Structure, function, and antigenicity of the SARS CoV-2 spike glycoprotein. Cell 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058.Epub 2020 Mar 9.
• 57. Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, et al. SARS-CoV-2 specific antibody responses in COVID-19 patients. MedRwix preprint on March 20, 2020.
• 58. Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis 2020 Mar 28. pii: ciaa344. doi: 10.1093/cid/ciaa344.
• 59. Guo L, Ren L, Yang S, Xiao M, Chang D , Yang F, et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis 2020 Mar 21. pii: ciaa310. doi: 10.1093/cid/ciaa310.
• 60. Lou B, Li T, Zheng S, Su Y, Li Z, Liu W, et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. Pre-print in MedRxiv on March 27, 2020.
• 61. Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z, et al. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis 2020; 94:49-52.
• 62. Yang T, Wang YC, Shen CF, Cheng CM. Point of care RNA based diagnostic device for COVID-19. Diagnostics 2020;10:165,1-3.